SCHEMBL6428558

SCHEMBL6428558

CNCCCNC(=O)c1ccc2[nH]nc(/C=C/c3ccc(F)cc3)c2c1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 8/20 0.39
DRD3 P35462 6/20 0.39
DRD4 P21917 4/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.37
MAPT P10636 2/20 0.36
HTR1A P08908 4/20 0.35
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
KCNA3 P22001 1/20 0.35
ABL1 P00519 1/20 0.35
BCR P11274 1/20 0.35
NAMPT P43490 1/20 0.35
HTR2A P28223 2/20 0.35
CCR2 P41597 2/20 0.35
THRB P10828 1/20 0.34
HTR2C P28335 1/20 0.34
HRH1 P35367 1/20 0.34
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6426055 0.91 DRD2 (0.38) DRD2DRD3DRD4HPGDSMN1; SMN2
SCHEMBL6430155 0.91 HDAC6 (0.39) DRD2DRD3DRD4HPGDSMN1; SMN2
SCHEMBL6425942 0.91 DRD2 (0.39) DRD2DRD3DRD4HPGDSMN1; SMN2
SCHEMBL6427398 0.90 DRD2 (0.38) DRD2DRD3DRD4HPGDSMN1; SMN2
SCHEMBL6427834 0.89 WNT1 (0.40) DRD2DRD3DRD4HPGDSMN1; SMN2
SCHEMBL6426050 0.89 POLB (0.39) DRD2DRD3DRD4HPGDMAPT
SCHEMBL6425796 0.88 DRD2 (0.37) DRD2DRD3DRD4HPGDSMN1; SMN2
SCHEMBL6426323 0.87 ABL1 (0.37) DRD2DRD3DRD4HPGDSMN1; SMN2
SCHEMBL6426305 0.87 DRD3 (0.37) DRD2DRD3DRD4HPGDSMN1; SMN2
SCHEMBL4153365 0.86 POLB (0.37) DRD3SMN1; SMN2ABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same CNKSR1, NR3C2, CSNK2B DRD2 1517/4885DRD3 1224/4885DRD4 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.